Copyright
©The Author(s) 2020.
World J Clin Oncol. Jun 24, 2020; 11(6): 348-369
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.348
Published online Jun 24, 2020. doi: 10.5306/wjco.v11.i6.348
Table 2 MicroRNAs associated with resistance to commonly used drugs in childhood acute leukemia treatment
Drug name | Most discriminating microRNAs |
Prednisolone | miR-99a, miR-125a, mir-128b, miR-210, miR-221, miR-550, miR-595, miR-633, miR-638, miR-652 |
L-asparaginase | miR-210, miR-454 |
Vincristine | miR-9, miR-99a, miR-100, miR-124, miR-125b, miR-126, miR-128b, miR-141, miR-200c, miR-218, miR-625, miR-633, miR-629, miR-1206 |
Prednisone | miR-15a, miR-18a, miR-16-1, miR-128b, miR-193a, miR-218, miR-223, miR-532, miR-550, miR-625, miR-633, miR-638 |
Daunorubicin | miR-99a, miR-100, miR-125b, miR-126, miR-199b, miR-203, miR-210, miR-335, miR-383, let-7c |
Doxorubicin | miR-125b |
Methotrexate | miR-595, miR-1206, miR-6083 |
Cytarabin | miR-562 |
Dexamethasone | miR-210 |
Imatinib | miR-203 |
Staurosporine | miR-125b |
- Citation: Szczepanek J. Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review. World J Clin Oncol 2020; 11(6): 348-369
- URL: https://www.wjgnet.com/2218-4333/full/v11/i6/348.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i6.348